Growth Hormone Promotes Hepatic Triglyceride Export in Humans
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf155 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Clemens Baumgartner und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III, Waehringer Guertel 18-20, Vienna 1090, Austria. Hauptthemen laut MEDLINE: Triglycerides, Liver, Human Growth Hormone, Acromegaly. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KLI, Austrian Science Fund.
Abstract (Originalsprache)
Context
Growth hormone (GH) reduces intrahepatic lipids (IHL) according to investigations in healthy volunteers and patients with acromegaly, a disease characterized by long-term GH excess.
Objective
This study investigated underlying antisteatotic pathways stimulated by short-term modulation of GH action.
Methods
Ten healthy male volunteers (26 ± 5 years, body mass index [BMI] 23 ± 3.4 kg/m2) were assessed before and after 1 week of daily subcutaneous treatment with either GH or a GH-receptor antagonist in a crossover study (EK Nr.1395/2020; Eudra-CT:2020-000831-34). The assessments comprised the quantification of IHL and hepatic ATP synthesis via magnetic resonance spectroscopy, assessment of very low-density lipoprotein (VLDL) secretion by an intralipid infusion protocol, and measurement of de novo lipogenesis (DNL) using stable isotope tracer techniques. In comparison, effects of long-term GH excess on VLDL secretion were investigated in patients with active acromegaly (54 ± 5 years; BMI 29.3 ± 3.6 kg/m2; insulin-like growth factor I of 3.1 ± 1 × upper limit of normal).
Results
GH treatment stimulated the secretion of VLDL-triglycerides by 26.1% (590.5 ± 282.3 mg/h vs 738.8 ± 424.9 mg/h, P = .035). Contrarily, mean DNL doubled after GH-receptor blockage without statistical significance (3.06 ± 1.95 vs 7.32 ± 8.43%, P = .107). Effects on hepatic ATP synthesis were not observed. Baseline hepatic VLDL secretion was comparable between volunteers and patients with acromegaly.
Conclusion
GH modulates hepatic lipid turnover via an increase in hepatic triglyceride export and repressed GH action tends to foster DNL, which may be of assistance for the development of future therapeutic strategies against metabolic dysfunction–associated steatotic liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Medical University of Vienna, Internal Medicine III, Waehringer Guertel 18-20, Vienna 1090, Austria.
- Center for Pathobiochemistry and Genetics, Medical University of Vienna, Institute of Medical Chemistry, Waehringer Straße 10, Vienna 1090, Austria.
- Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, High-Field MR Centre, Lazarettgasse 14, Vienna 1090, Austria.
- Cardiometabolic Risk Unit, Institute of Clinical Physiology, Consiglio Nazionale delle Ricerche (CNR), Via Giuseppe Moruzzi 1, Pisa 56124, Italy.
ORCID-Profile: Clemens Baumgartner, Matthäus Metz, Hannes Beiglböck, Paul Fellinger, Greisa Vila, Alexandra Kautzky-Willer, Amalia Gastaldelli, Thomas Scherer, Michael Krebs, Peter Wolf
Förderung
- KLI
- Austrian Science Fund
Zitieren
APA
Baumgartner, C., Metz, M., Beghini, M., Pfleger, L., Tosin, A., Koldyka, O., Beiglböck, H., Fellinger, P., Vila, G., Luger, A., Kautzky-Willer, A., Freudenthaler, A., Baumgartner-Parzer, S., Stangl, H., Krssak, M., Carli, F., Infelise, P., Gastaldelli, A., Scherer, T., …, & Wolf, P. (2025). Growth Hormone Promotes Hepatic Triglyceride Export in Humans. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf155
Vancouver
Baumgartner C, Metz M, Beghini M, Pfleger L, Tosin A, Koldyka O, et al. Growth Hormone Promotes Hepatic Triglyceride Export in Humans. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf155
BibTeX
@article{Baumgartner2025,
author = {Baumgartner, Clemens and Metz, Matthäus and Beghini, Marianna and Pfleger, Lorenz and Tosin, Anna and Koldyka, Oliver and Beiglböck, Hannes and Fellinger, Paul and Vila, Greisa and Luger, Anton and Kautzky-Willer, Alexandra and Freudenthaler, Angelika and Baumgartner-Parzer, Sabina and Stangl, Herbert and Krssak, Martin and Carli, Fabrizia and Infelise, Patrizia and Gastaldelli, Amalia and Scherer, Thomas and Krebs, Michael and Wolf, Peter},
title = {Growth Hormone Promotes Hepatic Triglyceride Export in Humans},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf155}
}
EUVIMED